| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ephedrine | alpha-1a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Asthma[MeSHID:D001249] Nose[MeSHID:D009666] Hypotension[MeSHID:D007022] Bronchial Diseases[MeSHID:D001982] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
1.18 | approved | agonist |
| ephedrine | beta-1 adrenergic receptor | small molecule | NA | drugbank | Asthma[MeSHID:D001249] Nose[MeSHID:D009666] Hypotension[MeSHID:D007022] Bronchial Diseases[MeSHID:D001982] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | agonist |
| ephedrine | beta-2 adrenergic receptor | small molecule | NA | drugbank , DGIDB | Asthma[MeSHID:D001249] Nose[MeSHID:D009666] Hypotension[MeSHID:D007022] Bronchial Diseases[MeSHID:D001982] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.77 | approved | agonist |
| ephedrine | dopamine d2 receptor | NA | Successful target | TTD , DGIDB | Asthma[MeSHID:D001249] Nose[MeSHID:D009666] Hypotension[MeSHID:D007022] Bronchial Diseases[MeSHID:D001982] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.12 | approved | unknown |
| ephedrine | sodium-dependent noradrenaline transporter | small molecule | NA | drugbank | Asthma[MeSHID:D001249] Nose[MeSHID:D009666] Hypotension[MeSHID:D007022] Bronchial Diseases[MeSHID:D001982] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inverse agonist |
| click here to return to the previous page | ||||||||